Shopping Cart
- Remove All
Your shopping cart is currently empty
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $155 | In Stock | |
| 5 mg | $433 | In Stock | |
| 10 mg | $692 | In Stock | |
| 25 mg | $1,060 | In Stock | |
| 50 mg | $1,430 | In Stock |
| Description | Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC). |
| Synonyms | RO5137382, RG-7686, GC33 |
| Molecular Weight | 145.58 kDa |
| Cas No. | 1365267-33-9 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.